7 news items
Lantheus Announces Executive Appointments to Accelerate Innovation
LNTH
15 May 24
and Cautionary StatementsThis press release contains "forward-looking statements" within the meaning of the Private Securities Litigation
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
BMY
CATX
LNTH
15 May 24
Litigation Reform Act of 1995. Statements in this press release that are not statements of historical fact are forward-looking statements. Words such as "may
Lantheus Reports First Quarter 2024 Financial Results
CATX
LNTH
2 May 24
of an ongoing Hatch Waxman litigation, the Company expects to launch 177Lu-PNT2003 in 2026.In January 2024, the Company announced it entered
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results
BMY
CATX
LNTH
28 Mar 24
Securities Litigation Reform Act of 1995. Statements in this press release that are not statements of historical fact are forward-looking statements
Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer
LNTH
28 Feb 24
release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, that are subject
8mr8cejt7j6tpf6551ke0g0dzujs2hsk34zz4zeiuqt9dgfimobh990
ACVA
AGRX
AMLX
22 Feb 24
the company reported better-than-expected fourth-quarter financial results and announced the settlement of its antitrust litigation related
5mcq1d7ffbm r2cnc
ACVA
ALTI
AMD
22 Feb 24
financial results and announced the settlement of its antitrust litigation related to the AutoIMS technology platform.
FTI Consulting
- Prev
- 1
- Next